Un consorcio de investigadores europeos, liderado por el Cima Universidad de Navarra, describe el primer caso de porfiria por deficiencia de ALA deshidratasa en una niña
Read moreResearchers from the Biomarkers of Cardiovascular Disease Progression group at the Institut de Recerca Sant Pau (IR Sant Pau) have identified a new mechanism by which complement C3, a key immune syste...
Read moreHuman gene maps contain major blind spots because they were built largely from the DNA sequences of people with European ancestry, according to a study published today in Nature Communications.
Read moreEl estudio, publicado en Nature Communications, revela que el factor de transcripción AP-1 actúa como un ‘interruptor’ que traduce las experiencias tempranas en mejoras o deficiencias cognitivas...
Read moreThe Centre for Genomic Regulation is participating in a new European research initiative that will explore why some wild African suid species can withstand African swine fever (ASF) while domestic pig...
Read moreIntegra Therapeutics, a global leader in cutting-edge gene writing tools to improve the efficacy, precision and safety of advanced therapies, announced today the appointment of Miles Gerson as the Ind...
Read moreA multiplex detection kit that targets Salmonella spp. and Listeria monocytogenes, like PRImeDETECT™ Salmonella & Listeria Detection Kit, enables users to test both pathogens in a single reaction. A...
Read moreInvestigadores del grupo SIBIUMA de la Universidad de Málaga e IBIMA Plataforma BIONAND han logrado un avance clave para la comprensión y el tratamiento de las enfermedades raras.
Read moreLos resultados podrían informar el futuro diseño de enfoques terapéuticos específicos para mutaciones para mejorar las opciones de tratamiento en niños con tumores cerebrales derivados de FGFR1. ...
Read moreFoxP2 is popularly known as the “language gene” since its role in speech difficulties was identified two decades ago. However, it is now known that its influence extends much further. It is a cruc...
Read moreThe research team led by the Institut de Recerca Joan de Déu (IRSJD) and the Hospital del Mar Research Institute has, for the first time, demonstrated the efficacy of a drug in animal models devel...
Read moreBiopharmaceutical company Oniria Therapeutics, Vall d’Hebron Institute of Oncology (VHIO) and Institut Català d’Investigació Química (ICIQ) will work together on the regulatory preclinical phas...
Read more